References
- Nakahara K., Ohno K., Hashimoto J., et al. Thymoma: results with complete resection and adjuvant postoperative radiation in 141 consecutive patients. J. Thorac. Cardiovasc. Surg. 1988; 95(6)1041–1047
- Urgesi A., Monetti U., Rossi G., et al. Radiother. Oncol. 1990; 19(3)273–280
- Kohman L.J. Chest 1997; 112(4 suppl.)296–300S
- Monden Y., Nakahara K., Iioka S., et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann. Thorac. Surg. 1985; 39(2)165–169
- Ruffini E., Mancuso M., Oliaro A., et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J. Thorac. Cardiovasc. Surg. 1997; 113(1)55–63
- Ogawa K., Totia T., Kakinohana Y., et al. Postoperative radiation therapy for completely resected invasive thymoma: prognostic value of pleural invasion for intrathoracic control. Jpn J. Clin. Oncol. 1999; 29(10)474–478
- Mayer R., Beham-Schmid C., Groell R., et al. Radiotherapy for invasive thymoma and thymic carcinoma. Strahlenther Oncol. 1999; 175(6)271–278
- Wang L.-S, Huang M.H., Lin T.S., et al. Malignant thymoma. Cancer 1992; 70: 443–450
- Uematsu M., Yoshida H., Kondo M., et al. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35(2)357–360
- Curran W., Kornstein M.J., Brooks J.J., et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J. Clin. Oncol. 1988; 6: 1722–1727
- Haniuda M., Kondo R., Numanami H., et al. Recurrence of thymoma: clinicopathological features, re-operation, and outcome. J. Surg. Oncol. 2001; 78(3)183–188
- Blumberg D., Port J.L., Weksler B., et al. Thymoma: a multivariate analysis of factors predicting survival. Ann. Thorac. Surg. 1995; 60: 908–914
- Maggi G., Casadio C., Cavallo A., et al. Thymoma: results of 241 operated cases. Ann. Thorac. Surg. 1991; 51(1)152–156
- Loehrer P.J., Jiroutek M., Aisner S., et al. Phase II trial of etoposide, ifosfamide, plus cisplatin in patients with advanced thymoma or thymic carcinoma: preliminary results from an ECOG coordinated intergroup trial. Proc. Annu. Meet Am. Soc. Clin. Oncol. 1998; 17: A118
- Loehrer P.J., Wang W., Ettinger D.S., et al. Phase II study of octreotide treatment in advanced or recurrent thymic malignancies. An Eastern Cooperative Oncology Group study. Proc. Annu. Meet Am. Soc. Clin. Oncol. 2002; 21: A1178
- Giaccone G., Ardizzoni A., Kirkpatrick A., et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J. Clin. Oncol. 1996; 14: 814–820